UF Health conducting COVID-19 trial study to effectiveness of ivermectin, 2 other FDA-approved drugs

This browser does not support the video element.

By Courtney Cole

JACKSONVILLE, Fla. — QUICK FACTS:

  • This is a nationwide study UF Health is participating in, referred to as ACTIV-6
  • As a whole, more than 3,000 people are enrolled so far
  • They’re planning to have more than 15,000 participants in the study once it is completed.
  • Jacksonville and Gainesville (UF Campuses) are hoping to enroll up to 200 patients.
  • You can sign-up or ask any further questions by calling this number: 833-385-1008
  • Study participants need to be over 30 years old, have a positive COVID-19 test in the past 10 days, and have two or more symptoms suggestive of COVID-19 infection

This story will be updated.